The authors state that long-term inflammation in patients with inflammatory bowel disease mediates the RANKL/NF-kB pathway and the use of hormones, which may contribute to the development of osteosarcopenia. They also emphasize the endocrine interaction between osteocytes and myocytes. This evidence concerns the gene TNFSF11 and inflammatory bowel disease.